Insider · CIK 0001506916

Meckler Jeffrey A

Reports to the SEC for 6 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001506916

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-10	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$26.52	+$265K	111,500
2026-09-10	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−14K sh	$67.46	−$944K	94,600
2026-09-10	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−3,100 sh	$68.09	−$211K	91,500
2026-09-10	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2026-09-10	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2026-09-10	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−1,200 sh	$66.15	−$79.4K	108,600
2026-09-10	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$17.44	+$174K	101,500
2026-09-10	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−1,700 sh	$65.39	−$111K	109,800
2026-05-19	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	91,500
2026-05-19	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2026-05-04	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−8,000 sh	$45.00	−$360K	87,500
2026-05-04	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,000 sh	$16.33	+$131K	95,500
2026-05-04	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,000 sh	—	—	0
2026-02-11	INDPIndaptus Therapeutics, Inc. · Warrants (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−3,033 sh	—	—	0
2026-02-11	INDPIndaptus Therapeutics, Inc. · Warrants (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−1,519 sh	—	—	0
2026-02-11	INDPIndaptus Therapeutics, Inc. · Warrants (right to buy)A Award	Director, Co-Chief Executive Officer	AAward	+12.1K sh	—	—	12,136
2026-02-11	INDPIndaptus Therapeutics, Inc. · Warrants (right to buy)A Award	Director, Co-Chief Executive Officer	AAward	+1,519 sh	—	—	1,519
2026-02-11	INDPIndaptus Therapeutics, Inc. · Warrants (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−12.1K sh	—	—	0
2026-02-11	INDPIndaptus Therapeutics, Inc. · Warrants (right to buy)A Award	Director, Co-Chief Executive Officer	AAward	+3,033 sh	—	—	3,033
2025-12-22	INDPIndaptus Therapeutics, Inc.A Award	Director, Co-Chief Executive Officer	AAward	+217K sh	$2.03	+$440K	229,929
2025-07-27	INDPIndaptus Therapeutics, Inc. · Common Stock WarrantsA Award	Director, Co-Chief Executive Officer	AAward	+12.1K sh	$8.30	+$101K	16,688
2025-07-27	INDPIndaptus Therapeutics, Inc.A Award	Director, Co-Chief Executive Officer	AAward	+6,068 sh	$8.30	+$50.4K	13,312
2025-05-15	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2025-05-15	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+6,500 sh	—	—	87,500
2025-04-10	INDPIndaptus Therapeutics, Inc. · sStock Option (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−1,500 sh	$0.04	−$55.5	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−3,750 sh	$0.04	−$138.75	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−4,750 sh	$0.04	−$175.75	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−1,563 sh	$0.04	−$57.831	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−1,250 sh	$0.04	−$46.25	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, Co-Chief Executive Officer	DDisposition to Issuer	−813 sh	$0.04	−$30.081	0
2024-11-25	INDPIndaptus Therapeutics, Inc. · Common Stock WarrantsA Award	Director, Co-Chief Executive Officer	AAward	+42.6K sh	$1.18	+$50K	42,553
2024-11-25	INDPIndaptus Therapeutics, Inc.A Award	Director, Co-Chief Executive Officer	AAward	+42.6K sh	$1.18	+$50K	202,859
2024-10-09	INDPIndaptus Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Co-Chief Executive Officer	AAward	+75K sh	—	—	75,000
2024-09-30	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	—	—	0
2024-09-30	TVTXTravere Therapeutics, Inc.S Sale	Director	SSale	−40K sh	$14.06	−$562K	81,000
2024-09-30	TVTXTravere Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$10.48	+$419K	121,000
2024-08-08	INDPIndaptus Therapeutics, Inc. · Common Stock WarrantsA Award	Director, Co-Chief Executive Officer	AAward	+84.9K sh	$1.82	+$155K	84,932
2024-08-08	INDPIndaptus Therapeutics, Inc.A Award	Director, Co-Chief Executive Officer	AAward	+84.9K sh	$1.82	+$155K	160,306
2024-05-08	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2024-05-08	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+6,500 sh	—	—	81,000
2024-01-22	INDPIndaptus Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Co-Chief Executive Officer	AAward	+100K sh	—	—	100,000
2023-05-17	TVTXTravere Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2023-05-17	TVTXTravere Therapeutics, Inc.A Award	Director	AAward	+4,500 sh	—	—	74,500
2023-01-18	INDPIndaptus Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Co-Chief Executive Officer	AAward	+100K sh	—	—	100,000
2022-11-21	INDPIndaptus Therapeutics, Inc.P Purchase	Director, Co-Chief Executive Officer	PPurchase	+9,600 sh	$1.90	+$18.2K	75,374
2022-11-18	INDPIndaptus Therapeutics, Inc.P Purchase	Director, Co-Chief Executive Officer	PPurchase	+400 sh	$1.76	+$705.48	65,774
2022-09-08	INDPIndaptus Therapeutics, Inc.P Purchase	Director, Co-Chief Executive Officer	PPurchase	+10.3K sh	$2.80	+$28.9K	65,374
2022-09-07	INDPIndaptus Therapeutics, Inc.P Purchase	Director, Co-Chief Executive Officer	PPurchase	+8,632 sh	$2.57	+$22.2K	55,066
2022-09-06	INDPIndaptus Therapeutics, Inc.P Purchase	Director, Co-Chief Executive Officer	PPurchase	+1,060 sh	$2.44	+$2,586.4	46,434
2022-06-06	INDPIndaptus Therapeutics, Inc.P Purchase	Director, Co-Chief Executive Officer	PPurchase	+19.7K sh	$2.63	+$51.9K	45,374

Recent filings

Accepted (ET)
Sep 114
Meckler Jeffrey A0001506916-26-000004
SEC(opens sec.gov)
May 214
Meckler Jeffrey A0001506916-26-000003
SEC(opens sec.gov)
May 64
Meckler Jeffrey A0001506916-26-000001
SEC(opens sec.gov)
Feb 134
Meckler Jeffrey A0001493152-26-006707
SEC(opens sec.gov)
Dec 294
Meckler Jeffrey A0001493152-25-029355
SEC(opens sec.gov)

Companies

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130